Stoke Therapeutics (STOK) 2025 Conference September 04, 2025 03:20 PM ET Speaker1Welcome to the Cantor Global Healthcare Conference. I'm Pete Stavropoulos, a biotech analyst with Cantor. With us, we have Stoke Therapeutics, a company we cover. I'm pleased to introduce Ian Smith, Interim Chief Executive Officer and Director of Stoke Therapeutics. Welcome, Ian. Let's start off with an introduction of yourself, a brief description of the company for those not familiar. You recently took the role of an Interim ...